Background: Otitis externa (OE) is a common disorder which can cause severe pain and discomfort with discharge and hearing loss. The majority of topical preparations for OE treatment contain a combination of steroids and antibiotics and are administered as ear drops. Otic powder preparations are less common. We found no studies which compared the efficacy of the two dosage forms.
Objective: The purpose of the study was to compare the healing process of the external ear canal when treated locally either with otic powder (Auricularum), a preparation containing antibiotic, steroidal and antimycotic components, or with otic drops (Dex-Otic), a commercial ear drop preparation containing antibiotic and steroidal components.
Methods: The study was designed as an open, randomised, comparative clinical trial. Ambulatory patients suffering from OE were examined by an ear specialist and randomly divided into an otic powder (Auricularum) treatment group and an ear drop (Dex-Otic) treatment group. Each treatment group was treated in accordance with the daily doses recommended by the manufacturers. Patients were treated for a period of 14 days and examined on days 0, 3, 7, 10 and 14. Clinical signs and symptoms recorded were pain, erythema, swelling and discharge.
Results: A total of 67 patients entered the study. The probability of healing within 7 days was 74% in the otic powder group as opposed to 40% in the ear drops group (log rank test, p = 0.0013). The probability of total pain relief after 3 days of treatment was 60% in the otic powder group compared to 53% in the ear drops group (log rank test, p = 0.0001).
Conclusion: We conclude that treatment with an otic powder (Auricularum) may promote earlier healing and pain relief than does treatment with otic drops (Dex-Otic).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1185/030079902125001263 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chemical stability and in vitro antimicrobial efficacy of diluted silver sulfadiazine powder and cream over a six-month period.
Vet Dermatol
December 2024
Department of Clinical Studies, University of Pennsylvania School of Veterinary Medicine, New Bolton Center, Kennett Square, Pennsylvania, USA.
Article Synopsis
- Silver sulfadiazine (SSD) is used in ear drops for treating otitis externa, but stability and effectiveness over time needed investigation.
- The study evaluated SSD's stability and antimicrobial activity when stored at room temperature in different formulations over six months, using specialized testing methods.
- Results showed that both powder and cream-based SSD maintained chemical stability and had strong antimicrobial effects, although the cream version had a higher chance of reduced effectiveness, especially after six months.
Water Condensation in the Nanoscale Pores of Pt/C Catalyst Particles and Its Impact on Catalyst Utilization: A Simulation Based on a Reconstructed Structure from Nanoimaging.
ACS Appl Mater Interfaces
April 2024
The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Article Synopsis
- In fuel cells that use a special kind of water-based technology, tiny platinum particles need water inside their small holes to work well.
- Researchers used advanced computer simulations to study how water collects in these tiny spaces, since they can't yet see it in real life.
- The study found that when there's low humidity, the way water forms a thin layer matters, but when it's really humid, water collects more in bigger holes, helping the platinum do its job better.
Potential Toxicity of Boric Acid Powder Otic Insufflation.
Otolaryngol Head Neck Surg
January 2024
Department of Otolaryngology, University of Florida, Gainesville, Florida, USA.
Objective: Boric acid (BA) powder is commonly used to treat otologic conditions, such as mastoid bowl inflammation and chronic otitis externa. Exposure to 50 mg per day is thought to cause systemic toxicity in humans. Inflamed skin and mucosal surfaces readily absorb BA.
View Article and Find Full Text PDFTwo Validated Chromatographic Methods for Determination of Ciprofloxacin HCl, One of its Specified Impurities and Fluocinolone Acetonide in Newly Approved Otic Solution.
J Chromatogr Sci
September 2022
Faculty of Pharmacy, Analytical Chemistry Department, Cairo University, Kasr el Aini Street, Cairo, 11562, Egypt.
Two sensitive, selective and precise chromatographic methods have been established for concomitant quantification of ciprofloxacin HCl (CIP), fluocinolone acetonide (FLU) along with ciprofloxacin impurity A (CIP-imp A). The first method was thin-layer chromatography (TLC-densitometry) where separation was accomplished using TLC silica plates 60 G.F254 as a stationary phase and chloroform-methanol-33%ammonia (4.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!